Sleep and Stress Peptide Research: DSIP, Selank, Semax and Pinealon

⚠ FOR LABORATORY RESEARCH AND EDUCATIONAL PURPOSES ONLY — NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Quick answer: Sleep and stress peptides are a small, preliminary research category. DSIP (delta sleep-inducing peptide) has the longest history in sleep-architecture studies, while Selank and Semax are examined for anxiolytic and stress-pathway signalling that intersects with sleep onset. Pinealon and Epitalon are studied for neuronal and circadian pathways respectively. Human trial evidence across this category remains limited, and no compound discussed here is approved as a sleep therapy.

Why This Category Requires Careful Interpretation

Sleep research presents a specific methodological challenge: sleep architecture is measurable by EEG, but subjective sleep quality depends on numerous confounding variables. Consequently, published peptide findings in this area frequently rest on small cohorts, animal models, or research conducted outside Western regulatory frameworks.

For that reason, this article states evidence strength for each compound rather than presenting them as interchangeable options. Notably, several peptides in this category are studied primarily for stress-pathway signalling, with sleep effects reported as secondary outcomes.

DSIP: The Longest Research History

DSIP (delta sleep-inducing peptide) is a nonapeptide first isolated in the 1970s from cerebral venous blood in rabbit models, named for reported increases in delta-wave (slow-wave) EEG activity.¹ Subsequent research examined its interaction with the hypothalamic-pituitary-adrenal axis, including reported effects on ACTH and cortisol responses under stress conditions.²

Evidence strength: decades of preclinical EEG work, but modern controlled human trials remain sparse and results across studies have been inconsistent. Additionally, researchers should note that DSIP has come under regulatory review in the United States, which may affect availability through compounding channels.

Laboratories investigating delta-wave and HPA-axis pathways can source research-grade DSIP with a batch-specific Certificate of Analysis.

Selank: Anxiolytic Signalling and Sleep Onset

Selank is a synthetic heptapeptide derived from the endogenous immunomodulatory peptide tuftsin. Published work — much of it conducted in Russia, where the compound holds regulatory approval — reports anxiolytic activity through GABAergic and monoaminergic pathways, without the sedation profile associated with benzodiazepines.³

Importantly, the literature does not describe Selank as acting directly on sleep architecture. Instead, studies report reduced anxiety-related arousal, which researchers treat as an indirect pathway to sleep onset. Laboratories investigating these pathways can source it as part of the Selank + Semax research combination.

Evidence strength: clinical trial data exists for anxiety endpoints; sleep-specific evidence is secondary and derived from those trials rather than primary insomnia studies.

Semax: Cognitive and Stress Pathways

Semax is a synthetic analogue of the ACTH(4-10) fragment, modified for stability. Research examines its influence on BDNF (brain-derived neurotrophic factor) expression and monoaminergic signalling, primarily in cognitive and neuroprotection models.⁴

Because it is often studied alongside Selank, the two are frequently supplied together for comparative work. However, their mechanisms differ: Semax research centres on cognitive and neurotrophic pathways, while Selank research centres on anxiolytic signalling.

Evidence strength: substantial Russian-language literature; limited independent Western replication.

Pinealon and Epitalon: Bioregulator Peptides

Pinealon is a short peptide (Ala-Glu-Asp) from the Khavinson bioregulator family. Published research proposes direct nuclear entry and modulation of gene expression in neuronal tissue, with studies examining neuroprotection under hypoxic and oxidative stress conditions.⁵

Researchers working in this area can review the Pinealon research vial and Epitalon specifications, both supplied with published COAs. Epitalon (Ala-Glu-Asp-Gly) is the tetrapeptide in this family studied specifically for pineal function, melatonin regulation, and circadian pathways — a distinct research focus from Pinealon’s neuronal work.

Evidence strength: substantial preclinical work within one research tradition; independent Western randomised trials are absent.

Research Summary

Peptide	Structure	Primary Research Pathway	Evidence Strength
DSIP	Nonapeptide	Delta-wave EEG activity, HPA axis	Preclinical depth; inconsistent human data
Selank	Heptapeptide (tuftsin analogue)	GABAergic anxiolytic signalling	Anxiety trials; sleep data secondary
Semax	ACTH(4-10) analogue	BDNF expression, monoamines	Regional literature; limited replication
Pinealon	Tripeptide (Ala-Glu-Asp)	Neuronal gene expression, hypoxia models	Preclinical only
Epitalon	Tetrapeptide (Ala-Glu-Asp-Gly)	Pineal function, melatonin, circadian regulation	Preclinical; regional clinical data

What the Literature Does Not Establish

• No approved sleep therapies. None of these peptides is FDA-approved for sleep or stress indications.
• Combination data is absent. No formal studies have evaluated combined protocols, despite their frequent discussion online.
• Sleep architecture versus subjective quality. Most reported effects concern measurable EEG parameters or anxiety scores, not validated sleep-quality endpoints.
• Geographic concentration. Much of the Selank, Semax, and bioregulator literature originates from a single research tradition, which limits independent verification.

Why Purity Matters in Neuropeptide Research

Neuropeptide studies are particularly sensitive to preparation quality. Specifically, sequence identity must be confirmed because closely related fragments produce different receptor interactions, and residual endotoxin can induce neuroinflammatory signalling that confounds behavioural and EEG readouts.

For these reasons, laboratories require documented HPLC purity, mass-spectrometry identity confirmation, and LAL endotoxin testing. LiveWell manufactures its research peptides in our own cGMP facility in Dallas, Texas — we are the manufacturer, not a reseller — and publishes batch-specific documentation on our COA page rather than supplying it on request only.

Handling and Storage

• Store lyophilized vials refrigerated at 2–8°C, protected from light and heat
• Reconstitute with bacteriostatic water; reconstituted material has a considerably shorter storage window
• Neuropeptides are generally more sensitive to freeze-thaw cycling than structural peptides — aliquot accordingly
• Follow your laboratory’s standard handling and disposal protocol

Frequently Asked Questions

Which peptides are studied for sleep?

DSIP has the longest research history, named for reported increases in delta-wave EEG activity. Selank and Semax are studied for anxiolytic and stress pathways that intersect indirectly with sleep onset, while Pinealon and Epitalon are examined for neuronal and circadian pathways. Human trial evidence is limited across the category.

What is DSIP?

DSIP (delta sleep-inducing peptide) is a nonapeptide first isolated in the 1970s from rabbit cerebral venous blood. Research examines delta-wave EEG activity and HPA-axis interactions including ACTH and cortisol responses. Modern controlled human trials remain sparse and inconsistent.

What is the difference between Selank and Semax?

Selank is a tuftsin-derived heptapeptide studied for anxiolytic signalling through GABAergic pathways. Semax is an ACTH(4-10) analogue studied for BDNF expression and cognitive pathways. They are often supplied together for comparative research, but their mechanisms are distinct.

What is the difference between Pinealon and Epitalon?

Both belong to the Khavinson bioregulator family. Pinealon (Ala-Glu-Asp) is studied for neuronal gene expression and neuroprotection under stress conditions, while Epitalon (Ala-Glu-Asp-Gly) is studied for pineal function, melatonin regulation, and circadian pathways.

Do these peptides act directly on sleep?

Only DSIP is studied primarily for sleep architecture itself. Selank and Semax are examined for stress and anxiety pathways, where any sleep-related outcome is reported as secondary. Researchers should design experiments accordingly rather than treating the category as uniform.

Are sleep peptides approved therapies?

No. None is FDA-approved for sleep or stress indications, and no formal studies have evaluated combined protocols. All material supplied by LiveWell is for in-vitro laboratory research only and is not for human or animal consumption.

How should neuropeptides be stored for research use?

Store lyophilized material refrigerated at 2–8°C, protected from light. Reconstitute with bacteriostatic water and aliquot to minimise freeze-thaw cycling, since neuropeptides are generally more sensitive to repeated cycling than structural peptides.

Related Research

Research compounds: DSIP · Selank + Semax Combo · Pinealon · Epitalon · All research vials · Certificates of Analysis

Continue the series: Mitochondrial Peptides in Research · Antimicrobial Peptides in Research · Collagen Peptide Research

External context: PubMed

References

1. Schoenenberger GA, Monnier M. Characterization of a delta-electroencephalogram-sleep-inducing peptide. PNAS. 1977;74(3):1282–1286.
2. Graf MV, Kastin AJ. Delta sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev. 1984;8(1):83–93.
3. Zozulya AA, et al. The efficacy of Selank in anxiety disorders. Zh Nevrol Psikhiatr. 2008;108(4):38–48.
4. Dolotov OV, et al. Semax, an ACTH(4-10) analogue, increases BDNF expression in the rat basal forebrain. Brain Res. 2006;1117(1):54–60.
5. Khavinson VKh, et al. Peptide regulation of gene expression and protein synthesis. Bull Exp Biol Med. 2011;150(6):708–711.
6. Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem. 2006;97(2):303–309.
7. Khavinson VKh, et al. Effect of epitalon on the pineal gland and circadian rhythms. Bull Exp Biol Med. 2003;135(4):380–383.

For research and educational purposes only. This article summarises published literature as a scientific reference for qualified researchers. It does not describe effects in humans, is not medical or health advice, and contains no dosing guidance. No compound discussed is approved to diagnose, treat, cure, mitigate, or prevent any disease. All LiveWell products are supplied strictly for in-vitro laboratory research and are not for human or animal consumption.